IRVINE, Calif., Aug. 16, 2005 (PRIMEZONE) -- "President Bush's stand-off with members of his own party is but one facet in a much broader stem cell battle," stated SmallCap Sentinel analyst, D.R. Clark. "Even as Republican Senators Tom Harkin D-Iowa and Arlen Spector R-Pennsylvania break ranks with the president, other stem cell funding battles are taking place at the state level."
"Elected officials in states like Illinois, Maryland, Missouri and more are making moves to secure or block funding for stem cell research," added Clark. "It is politically charged and heated and should be the source of both headlines and controversy in the coming days. I fully expect campaigns to be built on the stem cell issue."
An informational report titled "Looking at the Political Impact on Stem Cell Research" has been made available free of charge via financial courier StockUpTicks.com at www.SmallCapSentinel.com .
New Life Scientific (OTCBB:NWLF), which endeavors to blend Eastern European research and development with Western management, StemCells Inc. (Nasdaq:STEM), Aastrom Biosciences Inc. (Nasdaq:ASTM), and Geron Corp. (Nasdaq:GERN) are discussed in this informational report.
Individuals may also register to receive free future reports at:http://stockupticks.com/register.html
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that will affect the results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project its capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to its accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid thirty-six hundred dollars for preparation and distribution of this report and other advertising services by Emerging Markets Consulting LLC. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.